所有图片(1)

V-024

Vitamin D2 solution

1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant^®

所有图片(1)

别名:

Vitamin D2 solution

Empirical Formula (Hill Notation):

C₂₈H₄₄O

CAS号:

50-14-6

分子量:

396.65

MDL编号:

MFCD00166988

PubChem化学物质编号:

329828966

NACRES:

NA.24

质量水平

300

等级

certified reference material

形式

liquid

特点

(Snap-N-Shoot^®)
(Snap-N-Spike^®)

包装

ampule of 1 mL

manufacturer/tradename

Cerilliant^®

浓度

1 mg/mL in ethanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

mp

-144.0 °C

application(s)

clinical testing
clinical testing

格式

single component solution

储存温度

−70°C

InChI

1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1

InChI key

MECHNRXZTMCUDQ-RKHKHRCZSA-N

Gene Information

human ... VDR(7421)

一般描述

Vitamin D2 is a form of vitamin D also known as ergocalciferol. Marketed under trade names including Deltalin, Drisdol^®, and Calcidol^®, vitamin D2 is often used as a vitamin D supplement for individuals with vitamin D deficiency.

应用

This certified solution standard can be used Snap-N-Spike^® as a starting material in the preparation of calibrators or controls for clinical applications or Snap-N-Shoot^® in quality control testing of vitamin supplements, fortified foods or pharmaceutical preparations.

法律信息

CERILLIANT is a registered trademark of Cerilliant Corporation

Calcidol is a registered trademark of Patrin Pharma, Inc.

Drisdol is a registered trademark of Sanofi-Aventis

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Cerilliant Corporation

象形图

GHS02,GHS07,GHS08

警示用语：

Danger

危险声明

H225 - H319 - H373

预防措施声明

P210 - P233 - P240 - P241 - P305 + P351 + P338 - P314

危险分类

Eye Irrit. 2 - Flam. Liq. 2 - STOT RE 2 Oral

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(F)

57.2 °F

闪点(C)

14.0 °C

分析证书

请输入批号搜索分析证书（COA）。

原产地证书 (CofO)

请输入批号搜索原产地证书（COO）。

Quotes and Ordering

Bulk Quote-Order Product

Large Doses of Vitamin D Fail to Increase 25-Hydroxyvitamin D Levels or to Alter Cardiovascular Risk Factors in Obese Adolescents: A Pilot Study.

Sejal Shah et al.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 57(1), 19-23 (2015-04-16)

Vitamin D deficiency and cardiometabolic risk factors are common in obese adolescents. Observational studies demonstrate an inverse relationship among serum 25-hydroxyvitamin D (25OHD) and obesity, insulin resistance, and inflammatory cytokines. This pilot study explores if vitamin D supplementation could reduce

Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial.

Tom D Thacher et al.

Archives of disease in childhood, 99(9), 807-811 (2014-04-22)

To determine whether children with calcium-deficiency rickets have a better response to treatment with vitamin D and calcium than with calcium alone. Randomised controlled trial. Jos University Teaching Hospital, Jos, Nigeria. Nigerian children with active rickets treated with calcium carbonate

Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.

Gavin Dreyer et al.

PloS one, 9(7), e99461-e99461 (2014-07-10)

Vitamin D deficiency and endothelial dysfunction are non-traditional risk factors for cardiovascular events in chronic kidney disease. Previous studies in chronic kidney disease have failed to demonstrate a beneficial effect of vitamin D on arterial stiffness, left ventricular mass and

A review and clinical summary of vitamin D in regard to bone health and athletic performance.

Sara Neal et al.

The Physician and sportsmedicine, 43(2), 161-168 (2015-03-24)

The large amount of scientific literature regarding vitamin D can be overwhelming and confusing. Some organizations have made specific guidelines and recommendations regarding optimal blood levels of vitamin D. In the sports medicine literature, new information about the effects of

Treatment of bile acid amidation defects with glycocholic acid.

James E Heubi et al.

Hepatology (Baltimore, Md.), 61(1), 268-274 (2014-08-29)

Bile acid amidation defects were predicted to present with fat/fat soluble vitamin malabsorption with minimal cholestasis. We identified and treated five patients (one male, four females) from four families with defective bile acid amidation due to a genetically confirmed deficiency

查看所有相关文献